Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q3 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q3 2022 to Q1 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending March 31, 2023 was $37K.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $37K Mar 31, 2023 10-K 2023-06-21
Q4 2022 $37K Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $37K Sep 30, 2022 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.